Summary & Overview

CPT 20983: Percutaneous Cryoablation of Metastatic Bone Tumor

CPT code 20983 designates percutaneous cryoablation of metastatic bone tumors, a minimally invasive procedure that uses an extremely cold probe to destroy bone lesions and adjacent soft tissue. Nationally, this code is important as cryoablation offers a palliative and sometimes curative option for patients with painful or progressive metastatic bone disease and is frequently billed in hospital outpatient departments, ambulatory surgical centers, and interventional radiology settings.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, typical sites of service, common billing considerations, and a summary of payer coverage patterns. The publication highlights benchmarks and coding practice notes relevant to payers listed above, and outlines areas where policy updates and utilization trends affect coding and billing workflows.

This national summary is intended to inform health plan analysts, revenue cycle professionals, and clinicians involved in procedural oncology and interventional radiology about coding expectations and the clinical circumstances under which CPT code 20983 is applied.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareCPT 20983cryoablationbone metastasisinterventional radiologyoutpatient procedureambulatory surgical centeroncology procedureminimally invasive

Billing Code Overview

CPT code 20983 describes percutaneous cryoablation of one or more metastatic bone tumors using cryo energy applied through the skin. The provider destroys the targeted bone lesion(s) and any adjacent involved soft tissues; imaging guidance may be used to identify and target diseased tissue and to visualize and control treatment during the procedure.

Service type: Percutaneous image‑assisted tumor ablation procedure
Typical site of service: Hospital outpatient setting or ambulatory surgical center; may also be performed in interventional radiology suites or specialized procedural suites depending on facility resources and imaging needs.

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult with a history of metastatic solid tumor (for example, metastatic breast, lung, renal cell carcinoma) presenting with a symptomatic, radiographically confirmed metastatic bone lesion causing focal pain or at risk for local progression. The patient undergoes pre-procedure evaluation including review of oncologic history, cross-sectional imaging (CT or MRI) and, when indicated, PET to localize active disease. Multidisciplinary discussion occurs with medical oncology, radiation oncology and interventional radiology or orthopedic oncology to determine candidacy for percutaneous cryoablation.

On the day of service the patient is admitted to an outpatient interventional suite or hospital operating room depending on comorbidities and anesthesia needs. Conscious sedation or general anesthesia is administered. Imaging guidance (CT, fluoroscopy, or ultrasound) may be used to plan probe trajectory and monitor ice-ball formation. One or more cryoprobes are introduced percutaneously into the target lesion; cyclical freezing and thawing cycles are performed to achieve tumor necrosis and ablation of involved adjacent soft tissues as indicated. Post-procedure imaging documents ablation zone. The patient is monitored for immediate complications (bleeding, neurovascular injury) and discharged same day or admitted for observation based on clinical status and extent of procedure. Follow-up imaging is scheduled to assess local control and to coordinate additional systemic or local therapies as needed.

Coding Specifications

Modifier	Description	When to Use
`11`	Normally expected procedural service	Use when the service is performed as planned without unusual circumstances.
`22`	Increased procedural services	Use when the complexity or time of cryoablation is substantially greater than typical.
`23`	Unusual anesthesia	Use when medically necessary anesthesia is provided for a procedure that usually requires none.
`50`	Bilateral procedure	Use when anatomically appropriate bilateral bone lesions are treated in the same session and payer accepts bilateral reporting.
`51`	Multiple procedures	Use when cryoablation is performed with other distinct procedures on the same date and payer requires modifier for secondary procedures.
`52`	Reduced services	Use when the procedure is partially reduced or not completed as intended.
`53`	Discontinued procedure	Use when the procedure is terminated due to extenuating circumstances or patient safety.
`62`	Two surgeons	Use when two surgeons with different specialties actively participate during the same operative session.
`63`	Procedure performed on infants less than 4 kg	Rarely applicable; use for neonatal patients meeting criteria.
`66`	Surgical team	Use when services are provided by a surgical team for complex cases requiring multiple surgeons.
`78`	Return to OR for related procedure during postoperative period	Use when the patient returns to the OR for a related procedure after the initial cryoablation.
`79`	Unrelated procedure or service by same physician during postoperative period	(Not in provided list) Data not available in the input.
`LT`	Left side	Use for laterality reporting when only the left-sided lesion is treated and payer requires laterality.
`RT`	Right side	Use for laterality reporting when only the right-sided lesion is treated and payer requires laterality.

Taxonomy Code	Specialty	Notes
`207RC0000X`	Interventional Radiology	Common specialty performing percutaneous image-guided cryoablation.
`207XS0118X`	Pain Medicine	Pain specialists may perform or co-manage ablation for palliation of bone pain.
`2080P0207X`	Orthopedic Oncology	Orthopedic oncologists perform ablation for bone tumors, often in conjunction with stabilization.
`2084P0800X`	Surgical Oncology	Surgical oncologists may perform or coordinate local tumor control procedures.
`363L00000X`	Anesthesiology	Provides procedural sedation or general anesthesia for complex or prolonged cases.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C79.51`	Metastatic carcinoma to bone	Primary indication for percutaneous cryoablation to control focal bone metastasis and palliate pain.
`C79.52`	Metastatic carcinoma to bone marrow	Indicates marrow involvement where cryoablation may be considered for focal symptomatic lesions.
`M84.50XA`	Pathologic fracture, unspecified site, initial encounter	Cryoablation is used to treat tumor-associated lesions at risk for or associated with pathologic fracture.
`M49.05`	Collagen disorder of vertebra, with myelopathy (example)	Selected spinal involvement where focal ablation may be considered with caution; often requires multidisciplinary planning.
`C79.51`	Metastasis to bone (repeat entry avoided)	Duplicate entries are not included; each code above reflects common scenarios.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`20983`	Cryoablation, treatment of bone tumor(s), percutaneous, including imaging guidance when performed; first lesion	Primary code describing percutaneous cryoablation of metastatic bone tumor(s).
`76942`	Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation	May be reported when ultrasound guidance is used for probe placement during cryoablation.
`77012`	CT guidance for fluid drainage, needle placement and/or catheter placement; includes CT fluoroscopy when performed	Report when CT guidance is used for probe placement or intra-procedural monitoring.
`77021`	Magnetic resonance guidance for needle placement (eg, biopsy, aspiration, injection)	Report when MRI guidance is used for probe positioning during ablation.
`20610`	Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip)	May be performed adjunctively for symptomatic relief or diagnostic aspiration in the same session.
`11043`	Debridement; skin, subcutaneous tissue, and fascia (including primary closure, when performed)	May be reported when open debridement or limited soft tissue excision is performed in conjunction with ablation (use payer guidance for bundling).